| Balance Sheets | 2026-06-30 | 2026-03-31 | 2025-12-31 | |
|---|---|---|---|---|
| Cash and cash equivalents | 670,488 | 301,309 | 459,174 | |
| Prepaid expenses | - | 404,808 | - | |
| Prepaid expenses and other current assets | 310,964 | - | 159,985 | |
| Total current assets | 981,452 | 706,117 | 619,159 | |
| Total assets | 981,452 | 706,117 | 619,159 | |
| Accounts payable - trade | 1,674,005 | 1,371,309 | 1,512,090 | |
| Accrued expenses | 810,589 | 869,681 | 596,465 | |
| Financing liability | 162,208 | 240,698 | - | |
| Total current liabilities | 2,646,802 | 2,481,688 | 2,108,555 | |
| Total liabilities | 2,646,802 | 2,481,688 | 2,108,555 | |
| Common stock, 0.0001 par value 50,000,000 shares authorized 9,053,279 and 8,655,829 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively | 905 | 879 | 866 | |
| Additional paid-in capital | 9,976,954 | 8,661,447 | 7,801,539 | |
| Accumulated deficit | -11,643,209 | -10,437,897 | -9,291,801 | |
| Total stockholders deficit | -1,665,350 | -1,775,571 | -1,489,396 | |
| Total liabilities and stockholders deficit | 981,452 | 706,117 | 619,159 | |
ADAPTIN BIO, INC. (APTN)
ADAPTIN BIO, INC. (APTN)